210 related articles for article (PubMed ID: 15861702)
1. [Chronic Epstein-Barr virus infection].
Imashuku S; Teramura T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
[No Abstract] [Full Text] [Related]
2. Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
Gottschalk S
Bone Marrow Transplant; 2011 Jan; 46(1):18-9. PubMed ID: 20956953
[No Abstract] [Full Text] [Related]
3. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
[TBL] [Abstract][Full Text] [Related]
4. [Chronic active EBV infection].
Kimura H
Nihon Rinsho; 2006 Mar; 64 Suppl 3():630-4. PubMed ID: 16615549
[No Abstract] [Full Text] [Related]
5. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
6. [Chronic active Epstein-Barr virus infection].
Kimura H
Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus in the development of multiple sclerosis.
Ascherio A
Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964
[No Abstract] [Full Text] [Related]
8. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
9. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
[TBL] [Abstract][Full Text] [Related]
10. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of chronic active EBV infection].
Kawa K
Uirusu; 2002 Dec; 52(2):257-60. PubMed ID: 12685317
[No Abstract] [Full Text] [Related]
13. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Kawa K
Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
[No Abstract] [Full Text] [Related]
14. The human T cell immune response to Epstein-Barr virus.
Landais E; Saulquin X; Houssaint E
Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
[TBL] [Abstract][Full Text] [Related]
15. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection].
Babel N; Hammer MH; Reinke P
Dtsch Med Wochenschr; 2003 Mar; 128(11):548-50. PubMed ID: 12635027
[TBL] [Abstract][Full Text] [Related]
16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
17. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
[TBL] [Abstract][Full Text] [Related]
18. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
Pender MP
Brain; 2009 Dec; 132(Pt 12):3196-8. PubMed ID: 20008341
[No Abstract] [Full Text] [Related]
19. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
Au WY; Lam MF; Pang A; Leung RY; Kwong YL
Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
